• 1
    Rous P, Larimore LD. Relationship of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med 1920; 31: 609632.
  • 2
    Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973; 137: 179199.
  • 3
    Starzl TE, Watanabe K, Porter KA, Putnam CW. Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet 1976; 1: 821845.
  • 4
    Bucher NLR, Swaffield MN. Regulation of hepatic regeneration in rats by synergic action of insulin and glucagon. Proc Natl Acad Sci U S A 1975; 72: 11571160.
  • 5
    Baker AL, Jaspan JB, Heines NW, Hatfield GE, Krager PS, Schneider JF. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. Gastroenterology 1981; 80: 14101414.
  • 6
    Ozawa K, Yamada T, Honjo I. Role of insulin as a portal factor in maintaining the viability of liver. Ann Surg 1974; 180: 716719.
  • 7
    Ida T, Sato M, Yamaoka Y, Takeda H, Kamiyama Y, Kimura K, Ozawa K. Effect of insulin on mitochondrial oxidative phosphorylation and energy charge of the perfused guinea pig liver. J Lab Clin Med 1976; 87: 925933.
  • 8
    Bergen SS, Hilton JG, Van Itallie TB. Glycogenolytic effect of adenosine 3′,5′-monophosphate in the canine liver. Endocrinology 1966; 79: 10651068.
  • 9
    Exton JH, Park CR. Control of gluconeogenesis in liver: III. Effect of L-lactate, pyruvate, fructose, glucagon, epinephrine, and adenosine 3′,5′-monophosphate on gluconeogenic intermediates in the perfused rat liver. J Biol Chem 1969; 244: 14241433.
  • 10
    Butcher RW, Baird CE, Sutherland EW. Effects of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. J Biol Chem 1968; 243: 17051712.
  • 11
    Exton JH, Corbin JG, Park CR. Control of gluconeogenesis in liver: IV. Differential effects of fatty acids and glucagon on ketogenesis and gluconeogenesis in the perfused rat liver. J Biol Chem 1969; 244: 40954102.
  • 12
    Unger RH. Glucagon and the insulin:glucagon ratio in diabetes and other catabolic illnesses. Diabetes 1971; 20: 834838.
  • 13
    Nussbaum MS, Li S, Bower RH, McFadden DW, Dayal R, Fischer JE. Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio. J Parenter Enteral Nutr 1992; 16: 106109.
  • 14
    Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, Pisi E. Insulin and glucagon levels in liver cirrhosis: relationship with plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci 1979; 24: 594601.
  • 15
    Agrille JR, Rohweder-Dunn G, Brennan WA Jr, Kelly RT, Nosek MT. Mitochondrial function after acute alteration of the endogenous insulin-to-glucagon ratio. Biochem Biophys Res Commun 1987; 142: 315321.
  • 16
    Fath JJ, Ascher NL, Konstantinides FK, Bloomer J, Sharp H, Najarian JS, Cerra FB. Metabolism during hepatic transplantation: indicators of allograft function. Surgery 1984; 96: 664674.
  • 17
    Reilly JJ Jr, Halow GM, Gerhardt AL, Ritter PS, Gavaler JS, Thiel DV. Plasma amino acids in liver transplantation: correlation with clinical outcome. Surgery 1985; 97: 263270.
  • 18
    Luebbe N, Bornscheuer A, Grosse H, Ringe B, Gubernatis B, Seits W. Total body oxygen consumption during human liver transplantation. Anaesthesist 1988; 37: 211217.
  • 19
    Kamiike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988; 45: 138143.
  • 20
    Hansen BC, Jen K-LC, Pek SB, Wolfe RA. Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. J Clin Endocrinol Metab 1982; 54: 785791.
  • 21
    Balks HJ, Schmidt A, Prank K, Hemmer F, Muehlen A, Brabant G. Temporal pattern of pancreatic insulin and c-peptide secretion and of plasma glucose levels after nutritional stimulation. J Clin Endocrinol Metab 1992; 75: 11981203.
  • 22
    Pichlmayr R, Bockhorn WH, Neuhaus P. Lebertransplantation. In: BreitnerB, ed. Chirurgische Operationslehre. Vol 6. Baltimore: Urban & Schwarzenberg, 1983: 119.
  • 23
    Uno S, Itoh M, Kurono Y, Yamaoka Y, Kamiyama Y, Ozawa K. A simple and sensitive assay for blood ketone bodies using highly purified β-hydroxybutyrate dehydrogenase. Clin Chim Acta 1987; 168: 253255.
  • 24
    Taki Y, Gubernatis G, Yamaoka Y, Oellerich M, Yamamoto Y, Ringe B, Okamoto R, et al. Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation 1990; 49: 535539.
  • 25
    Nakatani T, Ozawa K, Asano M, Ukikusa M, Kamiyama Y, Tobe T. Changes in predominant energy substrate after hepatectomy. Life Sci 1981; 28: 257264.
  • 26
    Nishikawa K, Nishihira T, Taki Y, Morimoto T, Kamiyama Y, Ozawa K. Biological significance of enhanced ketogenesis in hepatectomized patients and aged rat liver mitochondria. Surg Res Commun 1988; 3: 251261.
  • 27
    Ozaki N, Ringe B, Bunzendahl H, Taki Y, Kuse ER, Kiuchi T, Yamauchi K, et al. Ketone body ratio as an indicator of early graft survival in clinical liver transplantation. Clin Transplantation 1991; 5: 4854.
  • 28
    Polonsky K, Jaspan JB, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, et al. Metabolism in c-peptide in the dog: in vitro demonstration of the absence of hepatic extraction. J Clin Invest 1983; 72: 11141123.
  • 29
    Faber OK, Hagen C, Binder C, Markussen J, Naithani VK, Blix PM, Kozuya H, et al. Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 1978; 62: 197203.
  • 30
    Roejdmark S, Bloom G, Chou MCY, Field JB. Hepatic extraction of exogenous insulin and glucagon in the dog. Endocrinology 1978; 102: 806813.
  • 31
    Takada Y, Yamaguchi T, Kiuchi T, Mori K, Shimahara Y, Kobayashi N, Yamaoka Y, et al. Effect of glucagon on hepatic energy charge and arterial ketone body ratio in normal rabbits. Gastroenterology 1991; 100: 10411045.
  • 32
    Sherwin RS, Fisher M, Bessoff J, Snyder N, Hendler R, Conn OH, Felig P. Hyperglucagonemia in cirrhotics: altered secretion and sensitivity to glucagon. Gastroenterology 1978; 74: 12241228.
  • 33
    Vilstrup H, Iversen J, Tygstrup N. Glucoregulation in acute liver failure. Eur J Clin Invest 1986; 16: 193197.
  • 34
    Tullson PC, Aprille JR. Regulation of mitochondrial adenine nucleotide content in newborn rabbit liver. Am J Physiol 1987; 253: E530535.
  • 35
    Nedelec JF, Capron-Laudereau M, Adam R, Demicoli J, Gugenheim J, Patry J, Pin ML, et al. Liver preservation: 31P and 13C NMR spectroscopic assessment of liver energy and metabolism after cold storage in Collins, Marshall, Ringer's lactate, UW and modified UW solutions. Transplant Proc 1989; 21: 13271329.
  • 36
    Draznin B, Solomons CC, Emler CA, Schalch DS, Sussman KE. Decreased insulin biding and degradation associated with depressed intracellular ATP content. Diabetes 1980; 29: 221226.
  • 37
    Cornell RP. Hyperinsulinemia and hyperglucagonemia in fasted rats during liver regeneration. Am J Physiol 1981; 240: E112118.
  • 38
    Ngala Kenda JF, de Hemptinne B, Lambotte L. Role of metabolic overload in the initiation of DNA synthesis following partial hepatectomy in rats. Eur Surg Res 1984; 16: 294302.
  • 39
    Mori K, Ozawa K, Kiuchi T, Takada Y, Yamaguchi T, Sadamoto T, Shimahara Y, et al. Insulinopenia as a risk factor in hepatectomy and its resolution by intraportal insulin administration. Am J Surg 1991; 162: 4349.
  • 40
    Schade DS, Eaton RP, Davis T, Akiya F, Phinney E, Kubica R, Vaughn EA, et al. The kinetics of peritoneal insulin absorption. Metabolism 1981; 30: 149155.